Karen Maubach
BTG International (United Kingdom)(GB)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Memory and Neural Mechanisms, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor(2002)621 cited
- → An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition(2006)241 cited
- → Identification of a Novel, Selective GABAAα5 Receptor Inverse Agonist Which Enhances Cognition(2003)140 cited
- → The role of endogenous cholecystokinin in the sensory transduction of luminal nutrient signals in the rat jejunum(1998)95 cited
- → GABAA Receptor Subtype Selective Cognition Enhancers(2003)90 cited
- → Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity(2002)81 cited
- → α5 subunit‐containing GABAA receptors affect the dynamic range of mouse hippocampal kainate‐induced gamma frequency oscillations in vitro(2004)75 cited
- → Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus(2002)73 cited
- → The role of prostaglandins in the bradykinin‐induced activation of serosal afferents of the rat jejunum in vitro(1999)70 cited
- → In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist(2009)70 cited